Article

Distributed Biomarker Discovery for Immuno-Oncology

2025-07-31

Abstract excerpt

<h4>Background</h4> Identifying robust predictive biomarkers for immuno-oncology (IO) therapy response remains challenging due to the complexity of tumor host interactions and the limited availability of public datasets. While achieving clinical relevance requires biomarkers that generalize across diverse datasets, privacy concerns surrounding sensitive clinical and molecular data further restrict data sharing, i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 162fc099-04f9-57d0-a779-373be221d8b5
DOI: 10.1101/2025.07.25.666789

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Distributed Biomarker Discovery for Immuno-OncologyDOI 10.1101/2025.07.25.666789Read

Advancing oncology with federated learning: transcending boundaries in breast, lung, and prostate cancer. A systematic reviewSemantic proximity Read

IOBR: Multi-omics Immuno-Oncology Biological Research to decode tumor microenvironment and signaturesSemantic proximity Read

Federated deep learning enables cancer subtyping by proteomicsSemantic proximity Read

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic featuresSemantic proximity Read

Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment across Multiple Tumor TypesSemantic proximity Read

Pan-cancer survival modeling reveals structural limits of genomic feature integration in immunotherapy outcomesSemantic proximity Read

The Oncology Research Information Exchange Network (ORIEN) – Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncologySemantic proximity Read

Scalable Patient-Level Prediction in a Trusted Research Environment: New Capabilities for the Veterans Precision Oncology Data CommonsSemantic proximity Read

Development and validation of the Immune Profile Score (IPS), a novel multi-omic algorithmic assay for stratifying outcomes in a real-world cohort of advanced solid cancer patients treated with immune checkpoint inhibitorsSemantic proximity Read

Federated Learning-Driven Collaborative Diagnostic System for Metastatic Breast CancerSemantic proximity Read

A Pan-Cancer Multi-Omic SuperLearner for Regulated Cell Death Survival TopologiesSemantic proximity Read

Navigating Multi-scale Cancer Systems Biology towards Model-driven Personalized TherapeuticsSemantic proximity Read